DexCom, Inc. vs Expeditors International of Wshngtn Inc — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.27B). The key difference: DexCom, Inc. is the larger of the two by market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | EXPD | |
|---|---|---|
Market Cap | $33.08B | $23.27B |
Sector | Health | Industrials |
52-Week High | $89.53 | $182.80 |
52-Week Low | $54.84 | $113.13 |
Enterprise Value | $32.53B | $22.80B |
Dividend Yield | — | 0.91% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →